Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-29

Clinical Trial Update: Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing recovery from rocuronium followed by sugammadex versus succinylcholine for anesthesia recovery; results posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rocuronium (rocuronium bromide)
  • Succinylcholine (succinylcholine chloride)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED | Results posted: 2019-03-29